Skip Navigation

European Heart Journal 2002 23(3):187-191; doi:10.1053/euhj.2001.2904
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by White, H. D.
Right arrow Articles by Wong, C. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by White, H. D.
Right arrow Articles by Wong, C. K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorials

Risk stratification and treatment benefits in patients with non-ST-elevation acute coronary syndromes

H. D. White and C. K. Wong

Green Lane Hospital, Auckland, New Zealand

References

  1. Boersma E, Pieper KS, Steyerberg EW. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation: results from an international trial of 9461 patients. Circulation. 2000;101:2557–2567[Abstract/Free Full Text]
  2. Cannon CP, Thompson B, McCabe CH. Predictors of non-Q-wave acute myocardial infarction in patients with acute ischemic syndromes: an analysis from the Thrombolysis in Myocardial Ischemia (TIMI) III Trials. Am J Cardiol. 1995;75:977–981[CrossRef][ISI][Medline]
  3. Hyde TA, French JK, Wong C-K, Straznicky IT, Whitlock RML, White HD. Four-year survival of patients with acute coronary syndromes without ST-segment elevation and prognostic significance of 0.5-mm ST-segment depression. Am J Cardiol. 1999;84:379–385[CrossRef][ISI][Medline]
  4. N Engl J Med. 1996;335:775–782[Abstract/Free Full Text]
  5. Antman EM, Cohen M, Bernink PJ. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2000;284:835–842[Abstract/Free Full Text]
  6. Hamm CW, Ravkilde J, Gerhardt W. The prognostic value of serum troponin T in unstable angina. N Engl J Med. 1992;327:146–150[Abstract]
  7. Lindahl B, Andrén B, Ohlsson J, Venge P, Wallentin L. Risk stratification in unstable coronary artery disease: additive value of troponin T determinations and pre-discharge exercise tests. Eur Heart J. 1997;18:762–770[Abstract/Free Full Text]
  8. Lindahl B, Venge P, Wallentin L. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. J Am Coll Cardiol. 1997;29:43–48[Abstract]
  9. Heeschen C, Hamm CW, Goldmann B. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. Lancet. 1999;354:1757–1762[CrossRef][ISI][Medline]
  10. Bahit MC, Shah M, Granger C. Prognostic significance of manifestations of acute congestive heart failure: results from GUSTO IIb [abstract]. J Am Coll Cardiol. 2000;35:213A
  11. McGuire DK, Emanuelsson H, Granger CB. Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes: findings from the GUSTO-IIb Study. Eur Heart J. 2000;21:1750–1758[Abstract/Free Full Text]
  12. Zhao X-Q, Théroux P, Snapinn SM, Sax FL. Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction: angiographic results from the PRISM-PLUS Trial (Platelet Receptor Inhibition for Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms). Circulation. 1999;100:1609–1615[Abstract/Free Full Text]
  13. Antman EM, McCabe CH, Gurfinkel EP. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 11B Trial. Circulation. 1999;100:1593–1601[Abstract/Free Full Text]
  14. Cohen M, Demers C, Gurfinkel EP. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med. 1997;337:447–452[Abstract/Free Full Text]
  15. Morrow DA, Antman EM, Snapinn SM, McCabe CH, Theroux P, Braunwald E. An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes: application of the TIMI risk score for UA/NSTEMI in PRISM-PLUS. Eur Heart J. 2002;23:223–229[Abstract/Free Full Text]
  16. Br Med J. 1994;308:81–106[Abstract/Free Full Text]
  17. Lancet. 1988;ii:349–360
  18. Waters D, Lam JYT. Is thrombolytic therapy striking out in unstable angina? Circulation. 1992;86:1642–1644[Free Full Text]
  19. Bertrand ME, Simoons ML, Fox KAA. Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation: recommendations of the Task Force of the European Society of Cardiology. Eur Heart J. 2000;21:1406–1432[Free Full Text]
  20. Ottani F, Galvani M, Nicolini FA. Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes. Am Heart J. 2000;140:917–927[CrossRef][ISI][Medline]
  21. Heeschen C, van den Brand MJ, Hamm CW, Simoons ML. Angiographic findings in patients with refractory unstable angina according to troponin T status. Circulation. 1999;104:1509–1514
  22. Lancet. 1996;347:561–568[CrossRef][ISI][Medline]
  23. N Engl J Med. 1998;338:1498–1505[Abstract/Free Full Text]
  24. N Engl J Med. 1998;338:1488–1497[Abstract/Free Full Text]
  25. N Engl J Med. 1998;339:436–443[Abstract/Free Full Text]
  26. Kong DF, Califf RM, Miller DP. Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease. Circulation. 1998;98:2829–2835[Abstract/Free Full Text]
  27. Lancet. 1999;354:708–715[CrossRef][ISI][Medline]
  28. Cannon CP, Weintraub WS, Demopoulos LA. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344:1879–1887[Abstract/Free Full Text]
  29. Lancet. 1999;354:701–707[CrossRef][ISI][Medline]
  30. Gum PA, Kottke-Marchant K, Poggio ED. Profile and prevalence of aspirin resistance among patients with heart disease: a prospective, comprehensive assessment [abstract]. Circulation. 2000;102:II-418
  31. Yamagishi S-I, Edelstein D, Du X-L, Brownlee M. Hyperglycemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction. Diabetes. 2001;50:1491–1494[Abstract/Free Full Text]
  32. Lancet. 1998;352:87–92[ISI][Medline]
  33. Braunwald E, Antman EM, Beasley JW. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). J Am Coll Cardiol. 2000;36:970–1062[Free Full Text]
  34. Circulation. 2000;102:I-172–I-203[Abstract/Free Full Text]
  35. Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes, National Institute for Clinical Excellence, London, England, September 2000
  36. White HD, Norris RM, Brown MA, Brandt PWT, Whitlock RML, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987;76:44–51[Abstract/Free Full Text]
  37. Heeschen C, Hamm CW, Bruemmer J, Simoons ML. Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial. J Am Coll Cardiol. 2000;35:1535–1542[Abstract/Free Full Text]
  38. Montalescot G, Philippe F, Ankri A. Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin. Circulation. 1998;98:294–299[Abstract/Free Full Text]
  39. Montalescot G, Collet JP, Lison L. Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina. J Am Coll Cardiol. 2000;36:110–114[Abstract/Free Full Text]
  40. Ohman EM, Granger CB, Harrington RA, Lee KL. Risk stratification and therapeutic decision making in acute coronary syndromes [commentary]. JAMA. 2000;284:876–878[Free Full Text]
  41. Newby LK, Storrow AB, Gibler WB. Bedside multimarker testing for risk stratification in chest pain units: the Chest Pain Evaluation by Creatine Kinase-MB, Myoglobin, and Troponin I (CHECKMATE) Study. Circulation. 2001;103:1832–1837[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by White, H. D.
Right arrow Articles by Wong, C. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by White, H. D.
Right arrow Articles by Wong, C. K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?